Transpact Enterprises Limited (BSE: 542765) is a Mumbai, Maharashtra-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹0 Cr, it ranks #6,118 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 13 in Pharmaceutical Product Distribution. At ₹105.70 (as of 16 Nov 2026), the share price is 55.0% below its 52-week high of ₹234.90 and 29.7% above its 52-week low of ₹81.47. The share price is down 50.4% over one year and up 11.3% over three months.
| Current Price | ₹105.70 |
|---|---|
| Market Cap | ₹0 Cr |
| BSE Code | 542765 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 48.4 |
| Return on Assets | 6.80% |
| 52-Week Range | ₹81.47 – ₹234.90 |
| 1-Year Price Change | -50.4% |
| 3-Month Price Change | +11.3% |
| Beta (1Y) | -0.28 |
| Headquarters | Mumbai, Maharashtra |
| Website | transpact.in |
Delivery averaged 96.3% of traded volume across 6 BSE sessions (26 Oct 2026 – 13 Nov 2026).
Transpact Enterprises Limited provides consulting and advisory services for corporate, financial, and commercial matters in India. The company offers management consulting, debt structuring, debt advisory, project appraisals, and other services by any person, corporate, firm, and association. It is also involved in dealing in shares, securities, commodities, currencies and derivatives, stock and share broker, sub-broker, authorized person, dealer, jobber, market maker, investment brokers, insurance broker, underwriter, and brokerage services. Transpact Enterprises Limited was incorporated in 2013 and is based in Mumbai, India.
1. Medical Products-This segment engages in the design, development, manufacturing, and distribution of therapeutic devices. It also provides rehabilitations services with analytics and management software system. 2. NA-NA 3. NA-NA 4. NA-NA
1. Medical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Transpact Enterprises Limited | ₹0 Cr | 48.4 | — | — | -50.4% |
Listed by market capitalisation. Ratios are shown for context only.
Transpact Enterprises Limited is trading at ₹105.70, with a market capitalisation of ₹0 Cr.
Transpact Enterprises Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Transpact Enterprises Limited has a P/E of 48.4.
Transpact Enterprises Limited is listed on the BSE under the scrip code 542765.
Transpact Enterprises Limited's share price is down 50.4% over one year and up 11.3% over three months. Its 52-week range is ₹81.47 to ₹234.90.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.